Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Conditions

Uveal Melanoma 1Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Pancreatic Cyst 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Leukemia 1Hip Fractures 1Fractures, Spontaneous 1Dysplastic Nevus Syndrome 1Colorectal Neoplasms, Hereditary Nonpolyposis 1COVID-19 1Breast Neoplasms 1Ataxia Telangiectasia 1

Interventions

pembrolizumab 35Specimen Handling 18Paclitaxel 15Magnetic Resonance Spectroscopy 15Biopsy 14Nivolumab 13Ipilimumab 13Carboplatin 13Gemcitabine 10Irinotecan 9abemaciclib 8Radiosurgery 8durvalumab 7atezolizumab 7Radiation 7Cisplatin 7Capecitabine 7130-nm albumin-bound paclitaxel 7trastuzumab deruxtecan 6olaparib 6avelumab 6Pemetrexed 6Docetaxel 6Cetuximab 6palbociclib 5osimertinib 5adagrasib 5Trastuzumab 5Fulvestrant 5Albumin-Bound Paclitaxel 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasm Metastasis × Data Collection × Clear all
NCT04387656 2026-05-27

NCI COVID-19 in Cancer Patients, NCCAPS Study

National Cancer Institute (NCI)

Active not recruiting
1,877 enrolled

COVID-19, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡